Coming Soon
Find information on Mild Cognitive Impairment due to Dementia, including clinical documentation, medical coding, and healthcare resources. Learn about MCI diagnosis, dementia progression, cognitive assessment, and care management. Explore relevant medical terminology, ICD-10 codes (G31.84), DSM-5 criteria, and best practices for healthcare professionals documenting and coding this condition. This resource provides valuable insights for physicians, nurses, and other clinicians involved in the care of patients with Mild Cognitive Impairment progressing to dementia.
Also known as
Mild cognitive impairment, so stated
Mild cognitive decline, not otherwise specified.
Mild cognitive disorder
Cognitive decline exceeding normal aging.
Other symptoms and signs involving cognitive functions
Unspecified cognitive symptoms and signs.
When to use each related code
| Description |
|---|
| Mild Cognitive Decline |
| Dementia due to Alzheimers |
| Frontotemporal Dementia |
Patient presents with subjective complaints consistent with mild cognitive impairment (MCI) likely due to dementia. The patient reports gradual decline in memory, particularly impacting short-term recall, affecting activities of daily living (ADLs) such as remembering appointments and following multi-step instructions. The patient denies significant changes in personality, behavior, or language skills. Family members corroborate the patient's reported memory concerns and note increased forgetfulness and difficulty with word-finding, but confirm the patient remains independent in basic ADLs. Cognitive assessment, including the Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE), reveals mild impairment in memory domains with scores within the MCI range. Neurological examination is otherwise unremarkable, and no focal neurological deficits are observed. Differential diagnoses considered include age-related cognitive decline, depression, and other medical conditions impacting cognition. Laboratory tests, including complete blood count (CBC), comprehensive metabolic panel (CMP), thyroid stimulating hormone (TSH), and vitamin B12 levels, were ordered to rule out reversible causes of cognitive decline. Neuroimaging, such as magnetic resonance imaging (MRI) of the brain, is recommended to assess for structural abnormalities and further evaluate for possible underlying Alzheimer's disease or other neurodegenerative processes. Based on the current clinical presentation, diagnostic criteria for MCI due to dementia are met. A treatment plan focusing on cognitive interventions, including memory strategies and cognitive stimulation therapy, was discussed with the patient and family. Patient education regarding disease progression, management strategies, and available support resources was provided. Follow-up appointment scheduled in three months to monitor symptom progression and reassess cognitive function. ICD-10 code G31.84 (Mild cognitive impairment, so stated) and relevant CPT codes for evaluation and management (E/M) services will be documented. The patient and family expressed understanding of the diagnosis and treatment plan.